0001837999-20-000001.txt : 20201228 0001837999-20-000001.hdr.sgml : 20201228 20201228113228 ACCESSION NUMBER: 0001837999-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 EFFECTIVENESS DATE: 20201228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMvention Therapeutix, Inc. CENTRAL INDEX KEY: 0001837999 IRS NUMBER: 822411198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-384379 FILM NUMBER: 201416012 BUSINESS ADDRESS: STREET 1: 701 W. MAIN STREET STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-593-6230 MAIL ADDRESS: STREET 1: 701 W. MAIN STREET STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001837999 IMMvention Therapeutix, Inc. 701 W. MAIN STREET SUITE 200 DURHAM NC NORTH CAROLINA 27701 919-593-6230 DELAWARE None None Corporation true 2017 Anil Goyal 701 W. Main Street Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Director Matthew Cohen 701 W. Main Street Suite 200 Durham NC NORTH CAROLINA 27701 Director Benjamin Scruggs 701 W. Main Street Suite 200 Durham NC NORTH CAROLINA 27701 Director Jenny Ting 701 W. Main Street Suite 200 Durham NC NORTH CAROLINA 27701 Director Biotechnology Decline to Disclose 06b false 2020-12-07 false true true true false 0 4402504 3902502 500002 false 4 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false IMMvention Therapeutix, Inc. Anil Goyal Anil Goyal CEO 2020-12-22